论文部分内容阅读
本文用较大剂量尿激酶一次性冲击治疗急性脑梗塞33例，并与小剂量尿激酶组35例及血塞通加胞二磷肥城组30例作对照，结呆显示大剂量溶栓组24小时治愈显效率为60．6％，明显优于小剂量溶栓组（14％）和对照组（3．3％），差异极其显著，P＜0．01。并对治疗的时间窗、尿激酶的剂量做了初步探讨，认为溶栓治疗25万单位以上尿激酶才能有效，100万单位以下是安全的。
In this paper, a larger dose of urokinase one-time impact treatment of acute cerebral infarction in 33 cases, and with low-dose urokinase 35 cases and Xuesaixiefei two phosphate Feicheng group of 30 cases as control, showing that the large dose of thrombolytic group 24 Hour cure rate was 60.6%, significantly better than the low-dose thrombolysis group (14%) and the control group (3.3%), the difference was extremely significant, P <0.01. And the treatment of time window, the dose of urokinase made a preliminary discussion, that the thrombolytic treatment of 250,000 units of urokinase to be effective, 100 million units the following is safe.